NOS2 and central nervous system cancer: The clonogenic potential of U-87 MG treated daily with 1400W for 10 days was significantly lower (p < 0.0001) than that in the control group, which indicated the crucial role of NOS2 activity on the capacity of the glioma cell line to produce progeny.